Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official Sort descending
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity NOT-CA-22-001 11/06/2024
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech NOT-NS-23-002 06/21/2024
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer NOT-CA-23-018 09/08/2024
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions RFA-NS-24-021 (R01 - Clinical Trial Optional) R01 Clinical Trial Optional 02/07/2025 Rachel Altshuler, Ph.D.
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices RFA-EB-22-002 (R18 Clinical Trial Not Allowed) R18 Clinical Trial Not Allowed 06/18/2025 Rachel Altshuler, Ph.D.
HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery NOT-NS-22-095 06/25/2025 Rachel Altshuler, Ph.D.
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment RFA-NS-22-034 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 12/07/2024 Rachel Altshuler, Ph.D.
HEAL Initiative: Studies to Enable Analgesic Discovery RFA-NS-25-012 (R61/R33 - Clinical Trial Not Allowed) R61, R33 Clinical Trial Not Allowed 01/16/2027 Rachel Altshuler, Ph.D.
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices RFA-NS-23-028 (RM1 Clinical Trial Optional) RM1 Clinical Trial Optional 06/10/2025 Rachel Altshuler, Ph.D.
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) NOT-NS-20-107 Clinical Trial Not Allowed 05/16/2024